home / stock / ptct / ptct news


PTCT News and Press, PTC Therapeutics Inc. From 05/20/24

Stock Information

Company Name: PTC Therapeutics Inc.
Stock Symbol: PTCT
Market: NASDAQ
Website: ptcbio.com

Menu

PTCT PTCT Quote PTCT Short PTCT News PTCT Articles PTCT Message Board
Get PTCT Alerts

News, Short Squeeze, Breakout and More Instantly...

PTCT - PTC Therapeutics Announces European Commission Returns Translarna(TM) Opinion to CHMP For Re-evaluation

PTC Therapeutics Announces European Commission Returns Translarna™ Opinion to CHMP For Re-evaluation PR Newswire - European Commission decides against adoption of negative opinion - - Translarna authorization remains active in Europe - - 2024 rev...

PTCT - PTC Therapeutics: Multiple Regulatory Submissions Along With Data Cuts

2024-05-14 15:35:05 ET Summary PTC Therapeutics, Inc. has submitted a New Drug Application for Upstaza for AADC Deficiency, with a PDUFA date set for November 13th, 2024. The company has several other regulatory milestones expected in 2024, including the resubmission of Translarna...

PTCT - PTC Therapeutics wins FDA priority review for gene therapy

2024-05-14 08:18:12 ET More on PTC Therapeutics PTC Therapeutics, Inc. (PTCT) Q1 2024 Earnings Call Transcript PTC Therapeutics, Inc. (PTCT) Q4 2023 Earnings Call Transcript PTC Therapeutics GAAP EPS of -$1.20 beats by $0.07, revenue of $210.12M beats by $46.3M ...

PTCT - PTC Therapeutics Announces FDA Acceptance and Priority Review of the BLA for Upstaza(TM)

PTC Therapeutics Announces FDA Acceptance and Priority Review of the BLA for Upstaza™ PR Newswire - PDUFA target action date of November 13, 2024 - WARREN, N.J. , May 14, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced toda...

PTCT - HHS panel to vote in Nov. on DMD screening for newborns

2024-05-09 18:44:45 ET More on Catalyst Pharmaceuticals, Sarepta Therapeutics, etc. Catalyst Pharmaceuticals, Inc. (CPRX) Q1 2024 Earnings Call Transcript Sarepta Therapeutics, Inc. (SRPT) Q1 2024 Earnings Call Transcript Sarepta Therapeutics: Growth Trajectory Alter...

PTCT - Boy given Pfizer experimental Duchenne muscular dystrophy therapy dies

2024-05-07 16:16:50 ET More on Pfizer, Sarepta Pfizer: Solid Earnings, But We're Not Out Of The Woods Yet Pfizer: Ignore The Dead Cat Bounce Pfizer Stock: Finally The Market Is Waking Up Pfizer hires Citi healthcare analyst Baum to lead strategy and innovatio...

PTCT - SQQQ, AAON, ARQT, SAVA, PTCT showing five-day downward plunge

2024-05-07 10:47:03 ET ProShares UltraPro Short QQQ (SQQQ) SQQQ is trading DOWN for the last 4 days, and it at trading at $10.69 with volume of 30,905,666 and a one day change of $-0.01 (-0.09%). ProShares UltraPro Short QQQ has a 52-week low of 10.05 and a 52-week high of $29.28. T...

PTCT - Objective long/short (PTCT) Report

2024-05-03 18:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

PTCT - XPEV, HSBC, PTCT, CTRE, AXSM showing five-day upward surge

2024-05-01 10:45:03 ET XPeng Inc (XPEV) XPEV is trading UP for the last 5 days, and it at trading at $8.16 with volume of 3,591,457 and a one day change of $0.03 (0.31%). XPeng Inc has a 52-week low of 6.55 and a 52-week high of $23.62. The business's 50-day moving average price is ...

PTCT - PTC Therapeutics, Inc. (PTCT) Q1 2024 Earnings Call Transcript

2024-04-25 23:52:09 ET PTC Therapeutics, Inc. (PTCT) Q1 2024 Earnings Conference Call April 25, 2024 16:30 ET Company Participants Jane Hanlon - Associate Director of Investor Relations Matthew Klein - Chief Executive Officer Eric Pauwels - Chief Business Officer...

Previous 10 Next 10